V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010494 | 250007700 | 1.86 | 0 | Adjuvant (A) | 2013-07-10 | 2013-07-10 | Cisplatin + Pemetrexed | 02 | N | 250030320 | CISPLATIN + PEMETREXED |
| 250010495 | 250007702 | 1.64 | null | null | 2015-02-08 | 2015-02-11 | Vinorelbine (oral) | N | N | 250030322 | VINORELBINE |
| 250010496 | 250007702 | 1.75 | 79 | Disease modification (D) | 2014-12-23 | 2015-01-12 | Cisplatin + Pemetrexed | 2 | N | 250030322 | CISPLATIN + PEMETREXED |
| 250010497 | 250007703 | 1.58 | 64 | Disease modification (D) | 2013-04-06 | 2013-04-13 | Cisplatin + Pemetrexed | 2 | N | 250030336 | CISPLATIN + PEMETREXED |
| 250010498 | 250007704 | 1.77 | 101 | Adjuvant (A) | 2017-02-13 | 2017-09-25 | RUXOLITINIB | 2 | N | 250030336 | RUXOLITINIB |
| 250010499 | 250007705 | 0 | 99 | null | 2018-01-11 | 2018-01-11 | Vinorelbine (oral) | N | N | 250030341 | VINORELBINE |
| 250010501 | 250007707 | 0 | 82 | Palliative (P) | 2016-04-03 | 2016-05-16 | Cisplatin + Pemetrexed | 02 | N | 250030354 | CISPLATIN + PEMETREXED |
| 250010502 | 250007713 | 1.75 | null | Disease modification (D) | 2014-02-20 | 2014-03-20 | Cisplatin + Pemetrexed | 99 | null | 250030372 | CISPLATIN + PEMETREXED |
| 250010503 | 250007714 | 1.78 | 62.9 | Palliative (P) | null | 2016-04-22 | Vinorelbine (oral) | N | N | 250030394 | VINORELBINE |
| 250010507 | 250007716 | null | 65 | Disease modification (D) | 2014-03-02 | 2014-03-15 | RUXOLITINIB | 2 | N | 250030412 | RUXOLITINIB |
| 250010508 | 250010867 | 1.63 | 78.6 | null | 2014-04-27 | 2015-07-16 | RUXOLITINIB | 02 | N | 250030413 | RUXOLITINIB |
| 250010509 | 250007717 | 1.62 | 82.3 | Disease modification (D) | 2017-02-07 | 2017-02-08 | RUXOLITINIB | 02 | N | 250030421 | RUXOLITINIB |
| 250010510 | 250007719 | 1.64 | 57 | Palliative (P) | 2014-02-04 | 2014-03-04 | RUXOLITINIB | 02 | N | 250030433 | RUXOLITINIB |
| 250010511 | 250007720 | 1.7 | null | null | null | 2017-08-10 | Cisplatin + Pemetrexed | null | null | 250030449 | CISPLATIN + PEMETREXED |
| 250010512 | 250007720 | null | 60.3 | Palliative (P) | 2013-08-28 | 2013-08-28 | Vinorelbine (oral) | N | N | 250030449 | VINORELBINE |
| 250010513 | 250007721 | 1.77 | null | Palliative (P) | 2018-09-12 | 2018-09-12 | Vinorelbine (oral) | 02 | N | 250030455 | VINORELBINE |
| 250010514 | 250007721 | 1.69 | null | Palliative (P) | null | 2019-02-04 | RUXOLITINIB | 99 | null | 250030455 | RUXOLITINIB |
| 250010515 | 250007721 | 1.74 | 79.6 | Not known (9) | 2017-09-11 | 2017-09-11 | RUXOLITINIB | 2 | N | 250030455 | RUXOLITINIB |
| 250010516 | 250007722 | 1.68 | 0 | Palliative (P) | 2015-08-03 | 2015-08-03 | Cisplatin + Pemetrexed | 2 | N | 250030497 | CISPLATIN + PEMETREXED |
| 250010517 | 250010870 | null | 79 | Disease modification (D) | 2016-10-04 | 2016-10-12 | RUXOLITINIB | 02 | Y | 250030505 | RUXOLITINIB |
| 250010518 | 250007723 | 1.65 | 63.9 | Palliative (P) | 2016-01-02 | 2016-01-02 | Vinorelbine (oral) | 02 | null | 250030507 | VINORELBINE |
| 250010519 | 250007724 | 1.75 | 0 | Palliative (P) | 2017-11-18 | 2017-11-20 | Vinorelbine (oral) | 2 | N | 250030509 | VINORELBINE |
| 250010520 | 250007725 | null | 66.8 | Palliative (P) | 2013-04-26 | 2013-05-15 | Cisplatin + Pemetrexed | 2 | N | 250030515 | CISPLATIN + PEMETREXED |
| 250010521 | 250007726 | null | null | Palliative (P) | 2017-11-19 | 2017-11-27 | Cisplatin + Pemetrexed | N | null | 250030520 | CISPLATIN + PEMETREXED |
| 250010522 | 250007727 | 1.71 | null | Palliative (P) | 2014-03-31 | 2014-03-31 | RUXOLITINIB | 02 | N | 250030530 | RUXOLITINIB |
| 250010523 | 250007728 | 1.73 | null | Adjuvant (A) | 2015-09-18 | 2015-09-18 | RUXOLITINIB | N | null | 250030531 | RUXOLITINIB |
| 250010525 | 250007730 | 1.74 | 66.8 | Palliative (P) | 2019-03-29 | 2019-04-10 | Vinorelbine (oral) | N | N | 250030535 | VINORELBINE |
| 250010526 | 250007732 | 1.7 | 57 | Disease modification (D) | 2017-01-15 | 2017-03-24 | Cisplatin + Pemetrexed | N | N | 250030536 | CISPLATIN + PEMETREXED |
| 250010527 | 250012104 | null | null | Palliative (P) | 2013-03-28 | 2013-04-11 | Vinorelbine IV | N | N | 250030546 | VINORELBINE |
| 250010528 | 250012104 | 0 | 65 | Disease modification (D) | 2015-02-16 | 2015-03-30 | Cisplatin + Pemetrexed | 02 | N | 250030546 | CISPLATIN + PEMETREXED |
| 250010529 | 250007733 | null | 116 | Palliative (P) | 2018-08-04 | 2018-08-23 | Vinorelbine (oral) | N | N | 250030550 | VINORELBINE |
| 250010530 | 250012105 | 0 | 0 | Palliative (P) | 2017-03-28 | 2017-04-24 | Cisplatin + Pemetrexed | N | N | 250030576 | CISPLATIN + PEMETREXED |
| 250010531 | 250007734 | 1.69 | 72.2 | Palliative (P) | 2015-02-06 | 2015-08-12 | Vinorelbine (oral) | N | N | 250030585 | VINORELBINE |
| 250010532 | 250007735 | 1.6 | 0 | Palliative (P) | 2014-07-08 | 2014-07-09 | Rituximab | N | N | 250030586 | PEG INTERFERON |
| 250010533 | 250007736 | 1.83 | 91.5 | Disease modification (D) | 2016-02-11 | 2016-04-27 | INTERFERON | N | N | 250030607 | ANAGRELIDE |
| 250010534 | 250007737 | 1.54 | null | Palliative (P) | 2017-03-18 | 2017-03-18 | Rituximab | 02 | N | 250030610 | ANAGRELIDE |
| 250010536 | 250007739 | 1.68 | null | Palliative (P) | 2018-07-15 | 2018-07-15 | CYCLOPHOSPHAMIDE | null | null | 250030653 | RITUXIMAB |
| 250010537 | 250007740 | 1.56 | 0 | Palliative (P) | 2016-08-13 | 2016-08-13 | CVP R | N | N | 250030654 | CVP R |
| 250010538 | 250007741 | 1.68 | 64.9 | Disease modification (D) | 2015-07-01 | 2015-07-29 | CYTARABINE + MITOXANTRONE | 02 | N | 250030659 | INTERFERON |
| 250010539 | 250007742 | 1.55 | 0 | Palliative (P) | 2015-01-19 | 2015-01-19 | CHOP R - 21 days | N | N | 250030659 | ANAGRELIDE |
| 250010540 | 250012106 | null | 71.4 | Palliative (P) | 2014-02-21 | 2014-03-01 | Pertuzumab + Trastuzumab IV | 2 | N | 250030681 | IMATINIB |
| 250010541 | 250007743 | null | null | Disease modification (D) | 2016-01-13 | 2016-01-13 | null | 02 | N | 250030683 | AZACITIDINE |
| 250010542 | 250007744 | 1.48 | 94.7 | Disease modification (D) | 2015-02-25 | 2015-02-25 | GemCarbo Days 1+8 | N | N | 250030683 | BUSULPHAN |
| 250010543 | 250007745 | 1.64 | 71.9 | Disease modification (D) | 2017-09-16 | 2017-09-16 | DACTINOMYCIN | N | null | 250030701 | DA |
| 250010544 | 250007746 | 0 | null | Disease modification (D) | 2015-10-15 | 2015-10-15 | CHOP R | 1 | N | 250030701 | RITUXIMAB |
| 250010545 | 250007747 | 1.68 | 66.8 | Palliative (P) | 2017-07-09 | 2017-07-09 | null | N | null | 250030717 | IRINOTECAN + MDG |
| 250010546 | 250007749 | 1.64 | null | Adjuvant (A) | 2013-07-02 | 2013-07-18 | BUSULFAN | N | N | 250030720 | ANAGRELIDE |
| 250010547 | 250007750 | null | null | Palliative (P) | 2016-06-05 | 2016-06-06 | BUSULFAN | N | N | 250030722 | PEG INTERFERON |
| 250010548 | 250007750 | null | 61.2 | Radical (R) | 2015-08-05 | 2015-08-05 | Nilotinib | N | N | 250030722 | PEG INTERFERON |
| 250010550 | 250007752 | null | 79.5 | Disease modification (D) | 2018-05-14 | 2018-07-05 | GemCarbo Days 1+8 | N | N | 250030753 | DA |